Alkem Laboratories Ltd. Stock price: Live updates

₹5425.0

-0.06% (-3.5)

Market Cap

₹64,824 Cr.

P/E

28.16

Key Ratios

Edit Ratio's

Market cap

64,824 Cr

28.16

Prom Holding

51.20 %

ROE (%)

18.07

ROCE (%)

22.08

Div Yield (%)

0.98

Sales

14,712 Cr

OPM (%)

20.43 %

Debt to Equity

0.09

Institutions

31.55 %

Individual < 2 lac

1.16 %

No. of Shareholders

62,835

Edit Ratio's

About

Alkem Laboratories Limited is a prominent global pharmaceutical company based in India. The co… Read more

Low

4716

52W Range

High

5934

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New

Edit rows

Forensics

13 Yes

Positive for this company

2 Neutral

Neutral for this company

2 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Net profit margin is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Working Capital

Working capital of the company seems to be under control
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Debt

Company should not have issues servicing its debt
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile

Market Share

2 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

9.27 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

0.04 %

(as of Jul 20)

Historic

Anti-Malarial - Market Share

0.37 %

(as of Nov 21)

Historic

Antineo Plastic - Market Share

0.03 %

(as of May 19)

Historic

Blood Related - Market Share

0.95 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

2.02 %

(as of Nov 21)

Historic

Dermatology - Market Share

1 %

(as of Nov 21)

Historic

Endocrinology - Market Share

5.61 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

1.09 %

(as of Nov 21)

Historic

Gynecology - Market Share

3.14 %

(as of Nov 21)

Historic

Neurological - Market Share

0.01 %

(as of Nov 21)

Historic

Ophthalmology - Market Share

3.32 %

(as of Nov 21)

Historic

Pain - Market Share

4 %

(as of Dec 22)

Historic

Pharmaceutical Sector - Market Share

0.96 %

(as of Nov 21)

Historic

Respiratory - Market Share

0.02 %

(as of Jul 22)

Historic

Sex Stimulants - Market Share

0.01 %

(as of May 20)

Historic

Stomatological - Market Share

0.98 %

(as of Nov 21)

Historic

Urology - Market Share

4.89 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up

Brand Wise Break-Up - India

Asset Break-Up

Operational Metrics

Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
Number of ANDA's Filed in Europe
Source
Number of ANDA's Approved in Europe
Source
Number of ANDA's Filed in Australia
Source
Number of ANDA's Approved by Australia
Source
Domestic Sales Growth - YoY (%)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Brands

Clavam

Taxim

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Suppliers

Borosil Renewables Ltd.
Bliss GVS Pharma Ltd.
IOL Chemicals And Pharmaceuticals Ltd.
Aarti Drugs Ltd.
TCPL Packaging Ltd.
ICE Make Refrigeration Ltd.
Zim Laboratories Ltd.
Empire Industries Ltd.

Showing 5 of 8

FAQs on Alkem Laboratories Ltd. Business

What does Alkem Laboratories do?

Alkem Laboratories Limited is a prominent Indian pharmaceutical company that develops, manufactures, and markets high-quality pharmaceutical products globally. It excels in acute and chronic therapeutic segments, supported by strong distribution networks and brand building.

Who are the competitors of Alkem Laboratories?

Alkem Laboratories major competitors are Glenmark Pharma., Abbott India, Ipca Laboratories, Aurobindo Pharma, Glaxosmithkline Phar, Ajanta Pharma, Gland Pharma.
Market Cap of Alkem Laboratories is ₹64,824 Crs.
While the median market cap of its peers are ₹41,042 Crs.

Is Alkem Laboratories financially stable compared to its competitors?

Alkem Laboratories seems to be less financially stable compared to its competitors.
Altman Z score of Alkem Laboratories is 7.9 and is ranked 6 out of its 8 competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Company Filing

	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Feb	May Aug	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Dec
Investor Presentation	Feb May	May Aug Nov	Mar Jun Sep Dec	Mar Jun Sep Dec	Feb Mar May Jun Aug Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Dec
Conference Call	Feb Jun	Mar Jun Nov	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Alkem Laboratories Ltd.

View the discussion on ValuePickr

Pharmaceuticals

GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Nutraceuticals- Industry Overview - Value Educator

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Pharma Compliance In-Depth - Amit Rajan

Deep Dive into Pharma Sector - Omkara Capital

How The Pharma Industry Works - PPFAS

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Alkem Laboratories Ltd.

Alkem Laboratories Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

13 Yes

2 Neutral

2 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Depreciation Effect

Other Income

Pledge

Retail Holding

Revenue Recognition

Promoter Holding

Price & Performance

Capex vs ROCE

ROE

Share price

Working Capital

Current vs Historic Valuation

Debt

ROCE Strength

Balance Sheet Strength

Sales Growth

Margin Stability

Market Share

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Therapeutic Area Wise Break-Up - Domestic

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Brand Wise Break-Up - India

UNLOCK PREMIUM

Asset Break-Up

UNLOCK PREMIUM

Operational Metrics

Peer Comparison

Brands

Corporate Actions

Suppliers

FAQs on Alkem Laboratories Ltd. Business

What does Alkem Laboratories do?

Who are the competitors of Alkem Laboratories?

Is Alkem Laboratories financially stable compared to its competitors?

Similar Companies

Company Filing

Discussions & Analysis

SIGN UP FOR FREE